| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/06/2010 | CN101622247A Cyclized derivatives as eg-5 inhibitors |
| 01/06/2010 | CN101622246A Polycyclic heteroaryl substituted triazoles useful as AXL inhibitors |
| 01/06/2010 | CN100577742C Cyanine dye labelling reagents |
| 01/06/2010 | CN100577659C Processes for producing indole compound |
| 01/06/2010 | CN100577658C 喹唑啉衍生物 Quinazoline derivatives |
| 01/06/2010 | CN100577163C Compounds effecting glucokinase |
| 01/06/2010 | CN100577160C Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 01/05/2010 | US7642359 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
| 01/05/2010 | US7642354 Polycyclic pyrazines as potassium ion channel modulators |
| 01/05/2010 | US7642352 Process for preparing 2,3-disubstituted indoles |
| 01/05/2010 | US7642351 2,4-Pyrimidinediamine compounds and their uses |
| 01/05/2010 | US7642278 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 01/05/2010 | US7642277 Non-nucleoside reverse transcriptase inhibitors |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642267 Benzimidazole and pyridylimidazole derivatives |
| 01/05/2010 | US7642265 Benzimidazoles and analogs thereof as antivirals |
| 01/05/2010 | US7642253 Histone deacetylase inhibitors |
| 01/05/2010 | US7642245 bactericide for treating drug resistant bacteria |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2392081C Pharmaceutically active isoindoline derivatives |
| 01/05/2010 | CA2383769C Indole derivatives |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 01/05/2010 | CA2185397C Arylalkyl-diazinones |
| 12/31/2009 | US20090326220 Tetrazole-Substituted Arylamides as P2X3 and P2X2/3 Antagonists |
| 12/31/2009 | US20090326024 Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same |
| 12/31/2009 | US20090326015 Compounds with embedded benzopyran motif for core structures and preparation method thereof |
| 12/31/2009 | US20090326011 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators |
| 12/31/2009 | US20090325979 Novel imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof |
| 12/31/2009 | US20090325974 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 12/31/2009 | US20090325973 Formulations containing pyridazine compounds |
| 12/31/2009 | US20090325955 Gyrase inhibitors and uses thereof |
| 12/31/2009 | US20090325935 Gyrase inhibitors and uses thereof |
| 12/31/2009 | US20090325209 Method and reagent for measuring nitroreductase enzyme activity |
| 12/31/2009 | US20090324720 Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same |
| 12/31/2009 | US20090324569 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 12/31/2009 | US20090324540 Compounds and compositions for delivering active agents |
| 12/30/2009 | WO2009158571A1 Heteroaryl compounds and uses thereof |
| 12/30/2009 | WO2009158375A1 Aza-cylic indole- 2 -carboxamides and methods of use thereof |
| 12/30/2009 | WO2009157860A1 New heterocyclic carboxamides for use as thrombin inhibitors |
| 12/30/2009 | WO2009157428A1 Phosphorescent light-emitting composition and light-emitting element comprising the composition |
| 12/30/2009 | WO2009157425A1 Composition, and light-emission element produced by using the composition |
| 12/30/2009 | WO2009157011A1 Process for the preparation of high purity sunitinib and its pharmaceutically acceptable salt |
| 12/30/2009 | WO2009157001A2 Process for preparation of candesartan cilexetil |
| 12/30/2009 | WO2009156837A2 Amorphous form of a 3-pyrrole substituted 2-indolinone malate salt |
| 12/30/2009 | WO2009156339A1 Isoquinolinone derivatives as nk3 antagonists |
| 12/30/2009 | WO2009156128A1 Pharmaceutical composition comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2- dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1 h-pyrrole-3-carboxamide |
| 12/30/2009 | WO2009137270A3 Azetidine derivatives |
| 12/30/2009 | WO2009136995A3 2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 12/30/2009 | WO2008142623A3 Tumor necrosis factor - alpha inhibitors |
| 12/30/2009 | EP2138490A1 New method for synthesis of fluoroquinolones |
| 12/30/2009 | EP2138489A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same |
| 12/30/2009 | EP2138486A1 Compound for organic electroluminescent device and organic electroluminescent device |
| 12/30/2009 | EP2138482A1 Bicyclic heterocyclic compound |
| 12/30/2009 | EP2138167A1 Pharmaceutical composition comprising N-[2-(Diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene) methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| 12/30/2009 | EP2137208A2 Compounds for diagnosing apoptosis |
| 12/30/2009 | EP2137177A2 Aurora kinase modulators and method of use |
| 12/30/2009 | EP2137166A1 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases |
| 12/30/2009 | EP2137164A1 Inhibitors of protein kinases |
| 12/30/2009 | EP2136635A1 Chemical compounds |
| 12/30/2009 | EP2049525B1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 12/30/2009 | EP2004625B1 C-met protein kinase inhibitors for the treatment of proliferative disorders |
| 12/30/2009 | EP1608632B1 Quinazolines useful as modulators of ion channels |
| 12/30/2009 | CN101616911A Chemical linkers with single amino acids and conjugates thereof |
| 12/30/2009 | CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/30/2009 | CN100575352C 1-(4- chloroanilino)-4-(4-methylpyridyl)-2,3-diazophenodiazine synthesis and uses |
| 12/30/2009 | CN100575346C Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 12/30/2009 | CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 12/30/2009 | CN100575341C Tetrahydro-indolone derivative and tetrahydro-indazolone derivatives and their use |
| 12/30/2009 | CN100575330C Novel compounds |
| 12/30/2009 | CA2766328A1 New therapeutic agents |
| 12/30/2009 | CA2729546A1 Compounds and compositions as kinase inhibitors |
| 12/30/2009 | CA2728852A1 Pharmaceutical composition comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide |
| 12/30/2009 | CA2728283A1 Isoquinolinone derivatives as nk3 antagonists |
| 12/30/2009 | CA2727925A1 New heterocyclic carboxamides for use as thrombin inhibitors |
| 12/30/2009 | CA2727455A1 Heteroaryl compounds and uses thereof |
| 12/30/2009 | CA2724310A1 Process for the preparation of high purity sunitinib and its pharmaceutically acceptable salt |
| 12/29/2009 | USRE41065 Such as (6,7-dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine for treatment of hyperproliferative diseases |
| 12/29/2009 | US7638549 Mitotic kinesin inhibitors |
| 12/29/2009 | US7638546 Imidazolyl derivatives |
| 12/29/2009 | US7638523 e.g. tert-butyl 2-(4-(2-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-5-yl)-2-fluorobenzamido)acetate; C-kit kinase receptor or stem cell factor inhibitors; asthma allergic sinusitis and rhinitis, atopic and allergic dermatitis, allergic contact rheumatoid arthritis, multiple sclerosis, lupus etc. |
| 12/29/2009 | US7638521 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
| 12/29/2009 | CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors |
| 12/29/2009 | CA2410311C Barbituric acid analogs as therapeutic agents |
| 12/29/2009 | CA2387013C 6-position substituted indolinones, the preparation thereof and their use as pharmaceutical compositions |
| 12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
| 12/29/2009 | CA2338543C Method of direct identification of compound efficacy at a g protein-coupled orphan receptor |
| 12/24/2009 | US20090318706 Process for the Preparation of Candesartan Cilexetil |
| 12/24/2009 | US20090318694 Cross-Linked Amine Compounds and Agents for Pest Control |
| 12/24/2009 | US20090318692 Process of making imatinib |
| 12/24/2009 | US20090318691 Novel Aromatic AZA Heterocycles, Method of Production and Use of the Material in Organic Electronics |
| 12/24/2009 | US20090318687 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds |
| 12/24/2009 | US20090318668 Water-Soluble CC-1065 Analogs and Their Conjugates |
| 12/24/2009 | US20090318525 Process For Preparing A 3-Pyrrole Substituted 2-Indolinone Malate Salt |
| 12/24/2009 | US20090318521 Synthesis of 4-Bromomethyl-2'-Formylbiphenyl and 4-Bromomethyl-2'-Hydroxymethylbiphenyl and Its Use in Preparation of Giotensin II Antagonists |
| 12/24/2009 | US20090318518 Indole and indoline cyclopropyl amide derivatives as ep4 receptor antagonists |
| 12/24/2009 | US20090318517 Novel Compounds 148 |
| 12/24/2009 | US20090318504 Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |